• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞在卵巢早衰中的生物学机制及应用前景。

Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure.

机构信息

The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.

Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, People's Republic of China.

出版信息

Medicine (Baltimore). 2022 Aug 12;101(32):e30013. doi: 10.1097/MD.0000000000030013.

DOI:10.1097/MD.0000000000030013
PMID:35960112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9371578/
Abstract

Premature ovarian failure (POF), also known as primary ovarian insufficiency (POI), refers to the loss of ovarian function in women after puberty and before the age of 40 characterized by high serum gonadotropins and low estrogen, irregular menstruation, amenorrhea, and decreased fertility. However, the specific pathogenesis of POF is unexplained, and there is no effective therapy for its damaged ovarian tissue structure and reduced reserve function. Mesenchymal stem cells (MSCs), with multidirectional differentiation potential and self-renewal ability, as well as the cytokines and exosomes they secrete, have been studied and tested to play an active therapeutic role in a variety of degenerative pathologies, and MSCs are the most widely used stem cells in regenerative medicine. MSCs can reverse POI and enhance ovarian reserve function through differentiation into granulosa cells (GCs), immune regulation, secretion of cytokines and other nutritional factors, reduction of GCs apoptosis, and promotion of GCs regeneration. Many studies have proved that MSCs may have a restorative effect on the structure and fertility of injured ovarian tissues and turn to be a useful clinical approach to the treatment of patients with POF in recent years. We intend to use MSCs-based therapy to completely reverse POI in the future.

摘要

卵巢早衰(POF),又称原发性卵巢功能不全(POI),是指青春期后和 40 岁前女性卵巢功能丧失,表现为血清促性腺激素升高和雌激素降低、月经不规则、闭经和生育能力下降。然而,POF 的具体发病机制尚不清楚,对于其受损的卵巢组织结构和储备功能下降也没有有效的治疗方法。间充质干细胞(MSCs)具有多向分化潜能和自我更新能力,以及其分泌的细胞因子和外泌体,已被研究和测试在多种退行性病变中发挥积极的治疗作用,是再生医学中应用最广泛的干细胞。MSCs 可以通过分化为颗粒细胞(GCs)、免疫调节、分泌细胞因子和其他营养因子、减少 GCs 凋亡和促进 GCs 再生,来逆转 POI 并增强卵巢储备功能。许多研究已经证明,MSCs 可能对受损卵巢组织的结构和生育能力具有修复作用,近年来已成为治疗 POF 患者的一种有用的临床方法。我们打算将来用基于 MSCs 的治疗方法来彻底逆转 POF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394e/9371578/922bda5caba1/medi-101-e30013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394e/9371578/f3fb436d981d/medi-101-e30013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394e/9371578/922bda5caba1/medi-101-e30013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394e/9371578/f3fb436d981d/medi-101-e30013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394e/9371578/922bda5caba1/medi-101-e30013-g002.jpg

相似文献

1
Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure.间充质干细胞在卵巢早衰中的生物学机制及应用前景。
Medicine (Baltimore). 2022 Aug 12;101(32):e30013. doi: 10.1097/MD.0000000000030013.
2
Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure.热休克预处理间充质干细胞抑制卵巢颗粒细胞凋亡增强化疗诱导的卵巢早衰修复作用。
Stem Cell Res Ther. 2018 Sep 26;9(1):240. doi: 10.1186/s13287-018-0964-4.
3
Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.卵巢早衰:间充质干细胞的发病机制及治疗潜力
J Mol Med (Berl). 2021 May;99(5):637-650. doi: 10.1007/s00109-021-02055-5. Epub 2021 Feb 27.
4
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model.人脐带间充质干细胞(hUC-MSCs)通过 VEGFA/PI3K/AKT/mTOR 通路减轻卵巢早衰大鼠模型中卵巢颗粒细胞的过度自噬。
J Ovarian Res. 2023 Sep 30;16(1):198. doi: 10.1186/s13048-023-01278-z.
5
Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.人羊膜间充质干细胞(hAD-MSC)移植通过旁分泌机制至少部分改善了卵巢早衰(POI)大鼠的卵巢功能。
Stem Cell Res Ther. 2019 Jan 25;10(1):46. doi: 10.1186/s13287-019-1136-x.
6
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice.单次和多次移植人脐带间充质干细胞对治疗小鼠卵巢早衰中卵巢功能恢复的影响。
J Ovarian Res. 2021 Sep 15;14(1):119. doi: 10.1186/s13048-021-00871-4.
7
Tracking of human embryonic stem cell-derived mesenchymal stem cells in premature ovarian failure model mice.人胚胎干细胞源性间充质干细胞在卵巢早衰模型小鼠中的示踪研究。
Biochem Biophys Res Commun. 2021 Nov 5;577:6-11. doi: 10.1016/j.bbrc.2021.08.063. Epub 2021 Aug 26.
8
Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage.干细胞与外泌体治疗原发性卵巢功能不全的疗效比较:与细胞一样有前景,但持续时间和剂量不同。
Stem Cell Res Ther. 2023 Jun 20;14(1):165. doi: 10.1186/s13287-023-03397-2.
9
Effects of hPMSCs on granulosa cell apoptosis and AMH expression and their role in the restoration of ovary function in premature ovarian failure mice.hPMSCs 对颗粒细胞凋亡和 AMH 表达的影响及其在卵巢早衰小鼠卵巢功能恢复中的作用。
Stem Cell Res Ther. 2018 Jan 31;9(1):20. doi: 10.1186/s13287-017-0745-5.
10
Human umbilical cord mesenchymal stem cells alleviate chemotherapy-induced premature ovarian insufficiency mouse model by suppressing ferritinophagy-mediated ferroptosis in granulosa cells.人脐带间充质干细胞通过抑制颗粒细胞中铁蛋白自噬介导的铁死亡缓解化疗诱导的卵巢早衰小鼠模型。
Free Radic Biol Med. 2024 Aug 1;220:1-14. doi: 10.1016/j.freeradbiomed.2024.04.229. Epub 2024 Apr 25.

引用本文的文献

1
Fertility Preservation in Female Children and Adolescent Cancer Patients.女童和青少年癌症患者的生育力保存
Children (Basel). 2025 May 16;12(5):647. doi: 10.3390/children12050647.
2
Exosomes derived from human amniotic mesenchymal stem cells promotes angiogenesis in hUVECs by delivering novel miRNA N-194.源自人羊膜间充质干细胞的外泌体通过递送新型微小RNA N-194促进人脐静脉内皮细胞的血管生成。
Mol Med. 2025 May 6;31(1):173. doi: 10.1186/s10020-025-01192-8.
3
Stem cell-based therapeutic potential in female ovarian aging and infertility.

本文引用的文献

1
A stem cell-derived ovarian regenerative patch restores ovarian function and rescues fertility in rats with primary ovarian insufficiency.干细胞衍生的卵巢再生贴片恢复了原发性卵巢功能不全大鼠的卵巢功能并挽救了其生育能力。
Theranostics. 2021 Aug 18;11(18):8894-8908. doi: 10.7150/thno.61690. eCollection 2021.
2
Mesenchymal Stem Cells in Premature Ovarian Insufficiency: Mechanisms and Prospects.间充质干细胞在卵巢早衰中的作用机制与前景
Front Cell Dev Biol. 2021 Aug 3;9:718192. doi: 10.3389/fcell.2021.718192. eCollection 2021.
3
Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases.
基于干细胞的治疗潜力在女性卵巢衰老和不孕中的应用。
J Ovarian Res. 2024 Aug 24;17(1):171. doi: 10.1186/s13048-024-01492-3.
4
Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks.干细胞与不孕症:临床应用及法律框架综述
J Pers Med. 2024 Jan 24;14(2):135. doi: 10.3390/jpm14020135.
5
Protective role of stem cells in POI: Current status and mechanism of action, a review article.干细胞在原发性卵巢功能不全中的保护作用:现状与作用机制,一篇综述文章
Heliyon. 2023 Dec 6;10(1):e23271. doi: 10.1016/j.heliyon.2023.e23271. eCollection 2024 Jan 15.
6
Tissue engineering and stem cell-based therapeutic strategies for premature ovarian insufficiency.针对卵巢早衰的组织工程和基于干细胞的治疗策略
Regen Ther. 2023 Nov 25;25:10-23. doi: 10.1016/j.reth.2023.11.007. eCollection 2024 Mar.
间充质干细胞衍生的细胞外囊泡在女性生殖疾病中的治疗作用。
Front Endocrinol (Lausanne). 2021 Jun 23;12:665645. doi: 10.3389/fendo.2021.665645. eCollection 2021.
4
Matrigel/Umbilical Cord-Derived Mesenchymal Stem Cells Promote Granulosa Cell Proliferation and Ovarian Vascularization in a Mouse Model of Premature Ovarian Failure.基质胶/脐带间充质干细胞促进卵巢早衰小鼠模型中颗粒细胞增殖和卵巢血管生成
Stem Cells Dev. 2021 Aug 1;30(15):782-796. doi: 10.1089/scd.2021.0005. Epub 2021 Jul 8.
5
Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency.人骨髓间充质干细胞治疗及其他治疗卵巢早衰的新方法。
Reprod Sci. 2021 Jun;28(6):1688-1696. doi: 10.1007/s43032-021-00528-z. Epub 2021 May 6.
6
Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).目前对卵巢早衰(POI)病因、症状和治疗选择的认识。
Front Endocrinol (Lausanne). 2021 Feb 25;12:626924. doi: 10.3389/fendo.2021.626924. eCollection 2021.
7
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model.人骨髓间充质干细胞 secretome 增强人颗粒细胞增殖和甾体生成,并恢复原发性卵巢功能不全小鼠模型的卵巢功能。
Sci Rep. 2021 Feb 25;11(1):4525. doi: 10.1038/s41598-021-84216-7.
8
Bone Marrow-Derived Mesenchymal Stem Cells Reverse Radiotherapy-Induced Premature Ovarian Failure: Emphasis on Signal Integration of TGF-β, Wnt/β-Catenin and Hippo Pathways.骨髓间充质干细胞逆转放疗诱导的卵巢早衰:强调 TGF-β、Wnt/β-连环蛋白和 Hippo 通路的信号整合。
Stem Cell Rev Rep. 2021 Aug;17(4):1429-1445. doi: 10.1007/s12015-021-10135-9. Epub 2021 Feb 16.
9
Advances in biomaterials and regenerative medicine for primary ovarian insufficiency therapy.用于原发性卵巢功能不全治疗的生物材料与再生医学进展。
Bioact Mater. 2020 Dec 26;6(7):1957-1972. doi: 10.1016/j.bioactmat.2020.12.008. eCollection 2021 Jul.
10
Human umbilical cord perivascular cells maintain regenerative traits following exposure to cyclophosphamide.人脐带血血管周细胞在接触环磷酰胺后保持再生特性。
Cancer Lett. 2021 Mar 31;501:133-146. doi: 10.1016/j.canlet.2020.12.035. Epub 2020 Dec 30.